Open Life Sciences, 2024 · DOI: https://doi.org/10.1515/biol-2022-0834 · Published: January 16, 2024
Parkinson's disease (PD) results from the degeneration of brain cells that produce dopamine, leading to motor and non-motor symptoms. Neural stem cells (NSCs) have the potential to replace damaged or lost neurons, offering a therapeutic option for PD. This study investigates the effectiveness of human NSCs (hNSCs) in reducing neurological deficits in a rat model of PD.
The study provides experimental evidence supporting the use of hNSCs in cell-based therapy for PD in clinical settings.
hNSCs have the potential to be a preventive method for PD.
hNSCs transplantation improves symptomatic motor behavior, prevents symptom progress, and increases striatal dopamine in a rat model of PD, indicating its therapeutic potential.